About
Technology
Issues
FAQ
Search
filter by year
2024 (411)
2023 (5,534)
2022 (12,900)
2021 (15,310)
2020 (14,742)
2010-2019 (107,613)
2000-2009 (62,364)
1990-1999 (36,669)
1980-1989 (20,933)
1970-1979 (8,249)
1960-1969 (3,332)
1950-1959 (1,289)
1900-1950 (1,569)
Similar Keywords
special (30,034)
special agents (86)
agents (272,196)
1-20 of (302,207 documents found)
2010
1.0K
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 60, 166-193.
Cite
Citations
Matthew Li (80, 6.9K)
2017
448
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 67, 507-524.
Cite
Citations
Matthew Li (80, 6.9K)
2020
306
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 70, 404-423.
Cite
Citations
Matthew Li (80, 6.9K)
2016
379
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 66, 309-325.
Cite
Citations
Matthew Li (80, 6.9K)
2013
245
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 63, 249-279.
Cite
Citations
Matthew Li (80, 6.9K)
2011
167
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 61, 31-49.
Cite
Citations
Matthew Li (80, 6.9K)
2007
212
Adjuvant Treatment of Colorectal Cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 57, 168-185.
Cite
Citations
Matthew Li (80, 6.9K)
2015
63
Molecular cancer prevention: Current status and future directions
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 65, 345-383.
Cite
Citations
Matthew Li (80, 6.9K)
2008
87
Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 58, 32-53.
Cite
Citations
Matthew Li (80, 6.9K)
2011
49
Clinical trials in the era of personalized oncology
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 61, 365-381.
Cite
Citations
Matthew Li (80, 6.9K)
2005
34
Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 55, 145-163.
Cite
Citations
Matthew Li (80, 6.9K)
2004
33
What Is New in Lymphoma?
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 54, 260-272.
Cite
Citations
Matthew Li (80, 6.9K)
2015
9.0K
Human-level control through deep reinforcement learning
Nature
(
13.7
★★★
), 518, 529-533.
Cite
Citations
Matthew Li (80, 6.9K)
2017
3.0K
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Nature Reviews Drug Discovery
(
21.5
★★★
), 16, 203-222.
Cite
Citations
Matthew Li (80, 6.9K)
2016
1.6K
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Chemical Reviews
(
23.0
★★★
), 116, 3436-3486.
Cite
Citations
Matthew Li (80, 6.9K)
2009
3.9K
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Nature Reviews Drug Discovery
(
21.5
★★★
), 8, 579-591.
Cite
Citations
Matthew Li (80, 6.9K)
2008
8.0K
Processable aqueous dispersions of graphene nanosheets
Nature Nanotechnology
(
15.6
★★★
), 3, 101-105.
Cite
Citations
Matthew Li (80, 6.9K)
2017
10.2K
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
American Journal of Nephrology
(
1.4
★★★
), 45, 160-169.
Cite
Citations
Matthew Li (80, 6.9K)
2017
1.3K
Trends in GPCR drug discovery: new agents, targets and indications
Nature Reviews Drug Discovery
(
21.5
★★★
), 16, 829-842.
Cite
Citations
Matthew Li (80, 6.9K)
2017
1.3K
Strategies and challenges for the next generation of antibody–drug conjugates
Nature Reviews Drug Discovery
(
21.5
★★★
), 16, 315-337.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.